Multiple Evanescent White Dot Syndrome Following COVID-19 mRNA Vaccination.


Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 2 8 2023
pubmed: 14 10 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

To report two cases of multiple evanescent white dot syndrome (MEWDS) following COVID-19 vaccination with the BNT162b2 mRNA vaccine. Two case reports. Case-1: A 40-yo Caucasian male, complained of blurred and decrease of vision in his left eye (OS) one week after the first dose of the BNT162b2 mRNA SARS-CoV-2 vaccine. Funduscopic examination OS showed multiple granular white dots with an aspect of foveal granularity. Case-2: A 23-yo woman also presented with defective and decrease of vision OS. She received her first dose of the BNT162b2 mRNA SARS-CoV-2 vaccine ten days before. Dilated fundus examination OS showed altered macular reflex with an aspect of foveal granularity. Multimodal imaging showed features of MEWDS in both cases. The anomalies found resolved spontaneously after 6 weeks. Inflammation and immune dysregulation induced by COVID-19 mRNA vaccine or its adjuvants could be involved in ocular adverse effects.

Identifiants

pubmed: 36228041
doi: 10.1080/09273948.2022.2127782
doi:

Substances chimiques

BNT162 Vaccine 0
COVID-19 Vaccines 0
RNA, Messenger 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1240-1244

Auteurs

Mohamed Ali Gargouri (MA)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Naoufel Yousfi (N)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Jonathan Toutain (J)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Selim Farès (S)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Raphaël Lejoyeux (R)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Eric Gabison (E)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Isabelle Cochereau (I)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Cherif Titah (C)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Georges Azar (G)

Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH